Surgical Treatment of Craniopharyngiomas in Adults: Comparison between Primary Surgery and Surgery for Recurrence

Abstract

Objective

Few studies have investigated the differences in outcomes between primary and repeat surgery for a craniopharyngioma in adults. As a result, a treatment concept for adult patients with a craniopharyngioma has not yet been established. The present study aimed to retrospectively analyze adult patients with craniopharyngioma to compare surgical outcomes between primary surgery and surgery for recurrence.

Methods

The demographic and clinical data of 68 adult patients with craniopharyngioma who had primary surgery (n=50) or surgery for recurrence (n=18) were retrospectively analyzed. In addition, the patients were followed up for an average of 38.6 months (range: 1–133 months).

Results

The cohorts of patients undergoing primary surgery or repeat surgery did not differ preoperatively in terms of demographic data, or radiological tumor features. However, patients with recurrent craniopharyngioma had significantly more pituitary hormone deficits and hypothalamo-pituitary disorders before surgery compared with patients with newly diagnosed craniopharyngioma. The success rate of complete resection in primary surgery was 53.2%. Even after repeat surgery, a satisfactory rate of complete resection of 35.7% was achieved. Operative morbidity was increased neither in patients with repeat surgery compared with those with primary surgery (postoperative bleeding P=0.560; meningitis P=1.000; CSF leak P=0.666; visual disturbance P=0.717) nor in patients with complete resection compared with those with partial resection. We found no difference in recurrence-free survival between initial surgery and repeat surgery (P=0.733). The recurrence rate was significantly lower after complete resection (6.9%) than after partial resection (47.8%; P<0.001).

Conclusion

Attempting complete resection is justified for not only those with newly diagnosed craniopharyngioma but also for those with recurrent craniopharyngioma. However, the surgeon must settle for less than total resection if postoperative morbidity is anticipated.

Keywords

craniopharyngioma / adulthood / transcranial / transsphenoidal / primary surgery / recurrence / recurrence-free survival

References

[1] FahlbuschR, HoneggerJ, PaulusW, et al.. Surgical treatment of craniopharyngiomas: experience with 168 patients. J Neurosurg, 1999, 90(2): 237-250

[2] PrietoR, RosdolskyM, HofeckerV, et al.. Craniopharyngioma treatment: an updated summary of important clinicopathological concepts. Expert Rev Endocrinol Metab, 2020, 15(4): 261-282

[3] MüllerHL. Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity. Curr Opin Endocrinol Diabetes Obes, 2016, 23(1): 81-89

[4] HoneggerJ, TatagibaM. Craniopharyngioma surgery. Pituitary, 2008, 11(4): 361-373

[5] MüllerHL. The diagnosis and treatment of cranio-pharyngioma. Neuroendocrinology, 2020, 110(9–10): 753-766

[6] Elowe-GruauE, BeltrandJ, BraunerR, et al.. Childhood craniopharyngioma: hypothalamus-sparing surgery decreases the risk of obesity. J Clin Endocrinol Metab, 2013, 98(6): 2376-2382

[7] BoguszA, BoekhoffS, Warmuth-MetzM, et al.. Posterior hypothalamus-sparing surgery improves outcome after childhood craniopharyngioma. Endocr Connect, 2019, 8(5): 481-492

[8] DandurandC, SepehryAA, LariMHA, et al.. Adult Craniopharyngioma: case series, systemic review, and meta-analysis. Neurosurgery, 2018, 83(4): 631-641

[9] CossuG, JouanneauE, CavalloLM, et al.. Surgical management of craniopharyngiomas in adult patients: a systematic review and consensus statement on behalf of the EANS skull base section. Acta Neurochir (Wien), 2020, 162(5): 1159-1177

[10] MendeKC, KellnerT, PetersennS, et al.. Clinical situation, therapy, and follow-up of adult craniopharyngioma. J Clin Endocrinol Metab, 2020, 105(1): dgz043

[11] TangB, XieSH, XiaoLM, et al.. A novel endoscopic classification for craniopharyngioma based on its origin. Sci Rep, 2018, 8(1): 10215

[12] Lopez-SernaR, Gómez-AmadorJL, Barges-CollJ, et al.. Treatment of craniopharyngioma in adults: systematic analysis of a 25-year experience. Arch Med Res, 2012, 43(5): 347-355

[13] ParkHJ, DhoYS, KimJH, et al.. Recurrence rate and prognostic factors for the adult craniopharyngiomas in long-term follow-up. World Neurosurg, 2020, 133: e211-e217

[14] ErfurthEM, HolmerH, FjalldalSB. Mortality and morbidity in adult craniopharyngioma. Pituitary, 2013, 16(1): 46-55

[15] SadashivamS, MenonG, AbrahamM, et al.. Adult Craniopharyngioma: the role of extent of resection in tumor recurrence and long-term functional outcome. Clin Neurol Neurosurg, 2020, 192: 105711

[16] LeeEJ, ChoYH, HongSH, et al.. Is the complete resection of craniopharyngiomas in adults feasible considering both the oncologic and functional outcomes?. J Korean Neurosurg Soc, 2015, 58(5): 432-441

[17] KimYH, KimCY, KimJW, et al.. Longitudinal analysis of visual outcomes after surgical treatment of adult craniopharyngiomas. Neurosurgery, 2012, 71(3): 715-721

[18] Van GompelJJ, NippoldtTB, HigginsDM, et al.. Magnetic resonance imaging-graded hypothalamic compression in surgically treated adult craniopharyngiomas determining postoperative obesity. Neurosurg Focus, 2010, 28(4): E3

[19] ApraC, EnachescuC, LaprasV, et al.. Is gross total resection reasonable in adults with craniopharyngiomas with hypothalamic involvement?. World Neurosurg, 2019, 129: e803-e811

[20] KaravitakiN, BrufaniC, WarnerJT, et al.. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Clin Endocrinol (Oxf), 2005, 62(4): 397-409

[21] MortiniP, LosaM, PozzobonG, et al.. Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series. J Neurosurg, 2011, 114(5): 1350-1359

[22] AdibSD, HerlanS, EbnerFH, et al.. Interoptic, Trans-lamina Terminalis, Opticocarotid Triangle, and Caroticosylvian Windows From Mini-Supraorbital, Frontomedial, and Pterional Perspectives: A Comparative Cadaver Study With Artificial Lesions. Front Surg, 2019, 6: 40

[23] KomotarRJ, StarkeRM, RaperDM, et al.. Endoscopic endonasal compared with microscopic transsphenoidal and open transcranial resection of craniopharyngiomas. World Neurosurg, 2012, 77(2): 329-341

[24] KoutourousiouM, Fernandez-MirandaJC, WangEW, et al.. The limits of transsellar/transtuberculum surgery for craniopharyngioma. J Neurosurg Sci, 2018, 62(3): 301-309

[25] AlliS, IsikS, RutkaJT. Microsurgical removal of craniopharyngioma: endoscopic and transcranial techniques for complication avoidance. J Neurooncol, 2016, 130(2): 299-307

[26] Van EffenterreR, BochAL. Craniopharyngioma in adults and children: a study of 122 surgical cases. J Neurosurg, 2002, 97(1): 3-11

[27] ShiXE, WuB, FanT, et al.. Craniopharyngioma: surgical experience of 309 cases in China. Clin Neurol Neurosurg, 2008, 110(2): 151-159

[28] PratR, GaleanoI, EvangelistaR, et al.. Transeyebrow supraorbital approach in large suprasellar craniopharyngioma surgery in adults: analysis of optic nerve length and extent of tumor resection. Original article. Acta Neurochir, 2017, 159: 873-880

[29] HoffmanHJ, De SilvaM, HumphreysRP, et al.. Aggressive surgical management of craniopharyngiomas in children. J Neurosurg, 1992, 76(1): 47-52

[30] YaşargilMG, CurcicM, KisM, et al.. Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients. J Neurosurg, 1990, 73(1): 3-11

[31] TurelMK, TsermoulasG, GonenL, et al.. Management and outcome of recurrent adult craniopharyngiomas: an analysis of 42 cases with long-term follow-up. Neurosurg Focus, 2016, 41(6): E11

[32] LeeMH, KimSH, SeoulHJ, et al.. Impact of maximal safe resection on the clinical outcome of adults with craniopharyngiomas. J Clin Neurosci, 2012, 19(7): 1005-1008

[33] WannemuehlerTJ, RubelKE, HendricksBK, et al.. Outcomes in transcranial microsurgery versus extended endoscopic endonasal approach for primary resection of adult craniopharyngiomas. Neurosurg Focus, 2016, 41(6): E6

[34] BaldéNM, DialloMM, PoirierJY, et al.. Long-term outcome of the adult onset craniopharyngiomas. Ann Endocrinol (Paris), 2007, 68(2–3): 186-190

[35] JungTY, JungS, ChoiJE, et al.. Adult craniopharyngiomas: surgical results with a special focus on endocrinological outcomes and recurrence according to pituitary stalk preservation. J Neurosurg, 2009, 111(3): 572-577